158 related articles for article (PubMed ID: 10595747)
1. In vivo cisplatin resistance depending upon canalicular multispecific organic anion transporter (cMOAT).
Minamino T; Tamai M; Itoh Y; Tatsumi Y; Nomura M; Yokogawa K; Suzuki H; Sugiyama Y; Ohshima T; Miyamoto K
Jpn J Cancer Res; 1999 Oct; 90(10):1171-8. PubMed ID: 10595747
[TBL] [Abstract][Full Text] [Related]
2. Conjugated bilirubin induces multidrug resistance-associated protein 2 mRNA expression and in vivo cisplatin resistance in rat hepatoma AH66 cells.
Tamai M; Ito Y; Mirura H; Tsukada H; Yokogawa K; Nomura M; Moritani S; Miyamoto K
Anticancer Res; 2003; 23(6C):4781-7. PubMed ID: 14981926
[TBL] [Abstract][Full Text] [Related]
3. Involvement of multidrug resistance-associated protein 2 in in vivo cisplatin resistance of rat hepatoma AH66 cells.
Itoh Y; Tamai M; Yokogawa K; Nomura M; Moritani S; Suzuki H; Sugiyama Y; Miyamoto K
Anticancer Res; 2002; 22(3):1649-53. PubMed ID: 12168849
[TBL] [Abstract][Full Text] [Related]
4. In vivo cisplatin resistance of rat ascites hepatoma AH66.
Minamino T; Nomura M; Tamai M; Moritani S; Ohshima T; Miyamoto K
Cancer Lett; 1996 Nov; 108(2):153-6. PubMed ID: 8973588
[TBL] [Abstract][Full Text] [Related]
5. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione.
Paulusma CC; van Geer MA; Evers R; Heijn M; Ottenhoff R; Borst P; Oude Elferink RP
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):393-401. PubMed ID: 10024515
[TBL] [Abstract][Full Text] [Related]
6. Characterization of naturally acquired multiple-drug resistance of Yoshida rat ascites hepatoma AH66 cell line.
Miyamoto K; Wakabayashi D; Minamino T; Nomura M; Wakusawa S; Nakamura S
Anticancer Res; 1996; 16(3A):1235-40. PubMed ID: 8702243
[TBL] [Abstract][Full Text] [Related]
7. Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2).
Kawabe T; Chen ZS; Wada M; Uchiumi T; Ono M; Akiyama S; Kuwano M
FEBS Lett; 1999 Aug; 456(2):327-31. PubMed ID: 10456333
[TBL] [Abstract][Full Text] [Related]
8. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter.
Chen ZS; Kawabe T; Ono M; Aoki S; Sumizawa T; Furukawa T; Uchiumi T; Wada M; Kuwano M; Akiyama SI
Mol Pharmacol; 1999 Dec; 56(6):1219-28. PubMed ID: 10570049
[TBL] [Abstract][Full Text] [Related]
9. Redistribution of canalicular organic anion transport activity in isolated and cultured rat hepatocytes.
Roelofsen H; Bakker CT; Schoemaker B; Heijn M; Jansen PL; Elferink RP
Hepatology; 1995 Jun; 21(6):1649-57. PubMed ID: 7768511
[TBL] [Abstract][Full Text] [Related]
10. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells.
Narasaki F; Oka M; Nakano R; Ikeda K; Fukuda M; Nakamura T; Soda H; Nakagawa M; Kuwano M; Kohno S
Biochem Biophys Res Commun; 1997 Nov; 240(3):606-11. PubMed ID: 9398612
[TBL] [Abstract][Full Text] [Related]
11. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation.
Taniguchi K; Wada M; Kohno K; Nakamura T; Kawabe T; Kawakami M; Kagotani K; Okumura K; Akiyama S; Kuwano M
Cancer Res; 1996 Sep; 56(18):4124-9. PubMed ID: 8797578
[TBL] [Abstract][Full Text] [Related]
12. Glutathione-S-transferase P-form dependent chlorambucil resistance in Yoshida rat ascites hepatoma cell lines.
Miyamoto K; Wakabayashi D; Minamino T; Nomura M
Cancer Lett; 1994 Apr; 78(1-3):77-83. PubMed ID: 7910111
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of organic anion in intracellular vesicles of cultured rat hepatocytes is mediated by the canalicular multispecific organic anion transporter.
Oude Elferink RP; Bakker CT; Roelofsen H; Middelkoop E; Ottenhoff R; Heijn M; Jansen PL
Hepatology; 1993 Mar; 17(3):434-44. PubMed ID: 8444418
[TBL] [Abstract][Full Text] [Related]
14. Novel properties of hepatic canalicular reduced glutathione transport revealed by radiation inactivation.
Mittur AV; Kaplowitz N; Kempner ES; Ookhtens M
Am J Physiol; 1998 May; 274(5):G923-30. PubMed ID: 9612274
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance in Yoshida rat ascites hepatoma cell lines.
Miyamoto K; Wakusawa S; Nakamura S; Tajima K; Hidaka H
Anticancer Res; 1992; 12(3):649-53. PubMed ID: 1622121
[TBL] [Abstract][Full Text] [Related]
16. Participation of the multispecific organic anion transporter in hepatobiliary excretion of glutathione S-conjugates, drugs and other xenobiotics.
Makowski P; PikuĊa S
Pol J Pharmacol; 1997; 49(6):387-94. PubMed ID: 9566041
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of P-glycoprotein-dependent multidrug resistance by an isoquinolinesulfonamide compound H-87 in rat ascites hepatoma AH66 cells.
Nakamura S; Minamino T; Nomura M; Wakusawa S; Miyamoto K; Hidaka H
Biol Pharm Bull; 1996 Jun; 19(6):886-9. PubMed ID: 8799494
[TBL] [Abstract][Full Text] [Related]
18. Species differences in the transport activity for organic anions across the bile canalicular membrane.
Ishizuka H; Konno K; Shiina T; Naganuma H; Nishimura K; Ito K; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1999 Sep; 290(3):1324-30. PubMed ID: 10454510
[TBL] [Abstract][Full Text] [Related]
19. An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells.
Chen ZS; Mutoh M; Sumizawa T; Furukawa T; Haraguchi M; Tani A; Saijo N; Kondo T; Akiyama S
Exp Cell Res; 1998 May; 240(2):312-20. PubMed ID: 9597004
[TBL] [Abstract][Full Text] [Related]
20. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells.
Koike K; Kawabe T; Tanaka T; Toh S; Uchiumi T; Wada M; Akiyama S; Ono M; Kuwano M
Cancer Res; 1997 Dec; 57(24):5475-9. PubMed ID: 9407953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
